Correlation Between CJ Cheiljedang and InnoTherapy

Can any of the company-specific risk be diversified away by investing in both CJ Cheiljedang and InnoTherapy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CJ Cheiljedang and InnoTherapy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CJ Cheiljedang and InnoTherapy, you can compare the effects of market volatilities on CJ Cheiljedang and InnoTherapy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CJ Cheiljedang with a short position of InnoTherapy. Check out your portfolio center. Please also check ongoing floating volatility patterns of CJ Cheiljedang and InnoTherapy.

Diversification Opportunities for CJ Cheiljedang and InnoTherapy

0.81

Correlation Coefficient

CJ Cheiljedang  InnoTherapy

Very poor diversification

The 3 months correlation between 097950 and InnoTherapy is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding CJ Cheiljedang and InnoTherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InnoTherapy and CJ Cheiljedang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CJ Cheiljedang are associated (or correlated) with InnoTherapy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InnoTherapy has no effect on the direction of CJ Cheiljedang i.e., CJ Cheiljedang and InnoTherapy go up and down completely randomly.

Pair Corralation between CJ Cheiljedang and InnoTherapy

Assuming the 90 days trading horizon CJ Cheiljedang is expected to under-perform the InnoTherapy. But the stock apears to be less risky and, when comparing its historical volatility, CJ Cheiljedang is 1.38 times less risky than InnoTherapy. The stock trades about -0.02 of its potential returns per unit of risk. The InnoTherapy is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  892,000  in InnoTherapy on October 4, 2024 and sell it today you would lose (68,000) from holding InnoTherapy or give up 7.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

CJ Cheiljedang  vs.  InnoTherapy

CJ Cheiljedang

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CJ Cheiljedang has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

InnoTherapy

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days InnoTherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with CJ Cheiljedang and InnoTherapy

The main advantage of trading using opposite CJ Cheiljedang and InnoTherapy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CJ Cheiljedang position performs unexpectedly, InnoTherapy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will offset losses from the drop in InnoTherapy's long position.

The idea behind CJ Cheiljedang and InnoTherapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.